Development and optimisation of inhalable egcg nano-liposomes as a potential treatment for pulmonary arterial hypertension by implementation of the design of experiments approach

HIGHLIGHTS

• who: Fatma Haddad et al. from the School of Pharmacy and Medical Sciences, University of Bradford, Bradford , DP, UK have published the article: Development and Optimisation of Inhalable EGCG Nano-Liposomes as a Potential Treatment for Pulmonary Arterial Hypertension by Implementation of the Design of Experiments Approach, in the Journal: Pharmaceutics 2022, 14, x FOR PEER REVIEW of /2022/
• what: The aim of this research was to develop and optimize an inhalable EGCG nano-liposome formulation aiming to overcome EGCG`s drawbacks by applying a design of experiments strategy. This can be attributed to the . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.